VOLITIONRX LTD - FORM 8-K/A - EX-10.21 - EXHIBIT 10.21 FULL AND FINAL SETTLEMENT - January 11, 2012

Attached files

file filename
8-K/A - 8-K/A2 CURRENT REPORT - VOLITIONRX LTDf8ka2011012_8kz.htm
EX-10.10 - EXHIBIT 10.10 APPOINTMENT AS NON EXECUTIVE DIRECTOR - VOLITIONRX LTDf8ka2011012_ex10z10.htm
EX-10.01 - EXHIBIT 10.1 PATENT LICENSE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z01.htm
EX-10.13 - EXHIBIT 10.13 APPOINTMENT AS NON EXECUTIVE DIRECTOR - VOLITIONRX LTDf8ka2011012_ex10z13.htm
EX-10.12 - EXHIBIT 10.12 PATENT LICENCE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z12.htm
EX-10.03 - EXHIBIT 10.3 EXTENSION LETTER AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z03.htm
EX-10.06 - EXHIBIT 10.6 LICENSE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z06.htm
EX-10.11 - EXHIBIT 10.11 APPOINTMENT AS NON EXECUTIVE DIRECTOR - VOLITIONRX LTDf8ka2011012_ex10z11.htm
EX-10.14 - EXHIBIT 10.14 LICENSE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z14.htm
EX-10.05 - EXHIBIT 10.5 CONTRACT REPAYABLE GRANT ADVANCE - VOLITIONRX LTDf8ka2011012_ex10z05.htm
EX-10.02 - EXHIBIT 10.2 AMENDMENT TO PRIMARY LICENSE - VOLITIONRX LTDf8ka2011012_ex10z02.htm
EX-10.07 - EXHIBIT 10.7 AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z07.htm
EX-10.08 - EXHIBIT 10.8 SHARE PURCHASE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z08.htm
EX-10.15 - EXHIBIT 10.15 SUPPLEMENTARY AGREEMENT TO THE SHARE PURCHASE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z15.htm
EX-10.04 - EXHIBIT 10.4 PRIMARY PATENT LICENSE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z04.htm
EX-10.09 - EXHIBIT 10.9 DEED OF NOVATION - VOLITIONRX LTDf8ka2011012_ex10z09.htm
EX-99.2 - EXHIBIT 99.2 VOLITION RX LIMITED PRO FORMA FINANCIAL STATEMENTS - VOLITIONRX LTDf8ka2011012_ex99z2.htm
EX-99.1 - EXHIBIT 99.1 SINGAPORE VOLITION PTE FINANCIAL STATEMENTS - VOLITIONRX LTDf8ka2011012_ex99z1.htm
EX-99.3 - EXHIBIT 99.3 UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS - VOLITIONRX LTDf8ka2011012_ex99z3.htm
EX-10.18 - EXHIBIT 10.18 CONSULTANCY AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z18.htm
EX-10.20 - EXHIBIT 10.20 SERVICE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z20.htm
EX-10.16 - EXHIBIT 10.16 DEED OF NOVATION - VOLITIONRX LTDf8ka2011012_ex10z16.htm
EX-10.19 - EXHIBIT 10.19 APPOINTMENT AS EXECUTIVE CHAIRMAN - VOLITIONRX LTDf8ka2011012_ex10z19.htm
EX-10.17 - EXHIBIT 10.17 PATENT LICENCE AGREEMENT - VOLITIONRX LTDf8ka2011012_ex10z17.htm
EX-3.1 - EXHIBIT 3.1 CERTIFICATE FOR RENEWAL AND REVIVAL OF CHARTER - VOLITIONRX LTDf8ka2011012_ex3z1.htm

Exhibit 10.21


150 Orchard Road

Orchard Plaza, 08-02

Singapore, 238841


T: +65 6333 7234

F: +65 6333 7235




Volition Research Limited

82Z Portland Place

London, W1B 1NS



11 August 2011



Dear Sirs


Full and Final Settlement between Volition Research Ltd and Singapore Volition Ptd. Limited.


Under the terms of the Service Agreement dated [Date] 2011 between Singapore Volition Pte. Limited (“Volition”) and Volition Research Ltd (“Research”), Volition has a debt owing to Research in the amount of US$105,000.00 (the “Debt”) for the provision of business development services over the period of the Agreement.


The Board of Volition after careful consideration proposes that an offer be made to Research to convert the amount of the Debt to 350,000 (Three hundred and fifty thousand) ordinary shares in Volition (the “Shares”) at a rate of US$0.30 per share (the “Conversion Rate”) in full satisfaction of the Debt.


By signing this letter Research hereby agrees and accepts the Shares as a full and final settlement of the Debt due under the Service Agreement and hereby releases Volition (and its parent or subsidiaries) from any further payment to Research for services under the Service Agreement.


Research warrants that in relation to the Shares that:


(a)

the Shares shall not be disposed of by Research without the prior written consent of the CEO of Volition; and

(b)

the Shares shall only be disposed of by Research in an orderly market manner.


Please indicate your acceptance of the conversion of this Debt to Shares as per the terms referred to above by signing below. By signing this letter the parties agree that a scanned or facsimile signature may substitute for and have the same legal effect as an original signature.


Yours faithfully


/s/ Cameron Reynolds                   

Cameron Reynolds

CEO

Singapore Volition Pte. Limited


Agreed and accepted by:


/s/ Dr. Martin Charles Faulkes.  

Dr. Martin Charles Faulkes

for and on behalf of

Volition Research Limited

 

___________________________________________________________________________________________________________

Singapore Volition Pte. Limited

(Registered in Singapore with Company No. 201016543R)

e-mail : info@volitionrx.com  website : www.volitionrx.com



Stock widget

Investing forum

VOLITIONRX LTD Reports